Prior regulatory approvals contain a vast and largely untapped knowledge base about what evidence regulators consider sufficient for specific approval decisions. Public assessment reports from the EMA, review memoranda from the FDA, and advisory committee transcripts collectively document thousands of regulatory decisions — what evidence was presented, what questions were raised, what additional data was requested, and what label language resulted from specific evidentiary configurations. This precedent knowledge is currently accessed primarily through regulatory affairs professionals' personal experience and informal knowledge networks. Structured mining transforms it into a systematically queryable resource.
The Regulatory Knowledge Mining Pipeline
Mining regulatory precedent requires a pipeline that can process highly varied document types — PDF assessment reports, HTML regulatory summaries, structured XML approval letters, and free-text advisory committee transcripts — and extract structured assertions about the regulatory decisions they document. The key extraction targets are: the product and indication approved, the study designs that formed the primary evidence base, the endpoints accepted as supportive of the approval, the label restrictions imposed and their evidentiary basis, and the post-marketing commitments required. Each extracted assertion is linked to its source document and annotated with the regulatory agency, approval date, and therapeutic area.
Precedent Search Applications
Once the regulatory precedent knowledge graph is populated, it supports several high-value search applications. Endpoint precedent search: what endpoints have been accepted by a specific regulatory agency for drugs in a specific indication, and what evidence level was required for each? Label restriction analysis: what are the most common label restrictions for drugs with a specific mechanism or in a specific patient population, and what evidence typically supports or removes them? Accelerated approval precedent: for which indications and biomarker types has accelerated approval been granted, and what post-marketing commitments were imposed? These queries currently require weeks of manual review; a semantic regulatory knowledge graph answers them in minutes.
Competitive Intelligence Integration
Regulatory precedent intelligence combines naturally with competitive intelligence: knowing that a competitor's approval in a neighbouring indication was supported by a specific trial design, with a specific endpoint, at a specific evidence level, is directly relevant to programme strategy decisions. A knowledge graph that integrates regulatory approval data with competitive product data — product ontology, indication linkages, development timelines — supports the kind of integrated regulatory-commercial analysis that senior development teams need but currently assemble manually from disparate sources.
